![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » SANOFI-AVENTIS KK, ASTELLAS DISCONTINUE MARKETING ALLIANCE
SANOFI-AVENTIS KK, ASTELLAS DISCONTINUE MARKETING ALLIANCE
Sanofi-Aventis KK and Astellas Pharma Inc., Japan, have agreed to discontinue the marketing alliance on September 30, 2006 for Ketek Tablets 300 mg (generic name: telithromycin), ketolide antibiotic. BioSpectrum (http://www.biospectrumasia.com/content/220806JPN1401.asp)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct